Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Profile Treatment Approach Name | RET Inhibitor |
| Profile Name | RET act mut |
| Drug Class | RET Inhibitor 53 |
| Therapy |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (22146228) | Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib). | Full reference... |
| (24705026) | Mechanisms of RET signaling in cancer: current and future implications for targeted therapy. | Full reference... |
| (21551259) | In vitro transforming potential, intracellular signaling properties, and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu, and Arg886Trp. | Full reference... |